Thoma Bravo cybersecurity investments - Business-News-Today.com

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

Acumen Pharmaceuticals faces strategic reset with $78.6m cash after Alzheimer’s drug failure

NRx Pharmaceuticals moves toward ketamine sales after FDA approval of domestic injectable product

Intellect Design Arena (INTELLECT) near Rs 505: Is the 16% share-price crash justified when AI revenue is growing but profits are not?

Affle 3i to acquire Perion for $420m, but its $228m cash balance changes the deal maths

CyberArk to acquire Venafi for $1.54 billion to expand capabilities in machine identity security and increasing market presence.

Read More

Technology Industry News

CyberArk announces $1.54bn acquisition of Venafi to enhance machine identity security

CyberArk (NASDAQ: CYBR), a global leader in identity security, has entered into a definitive agreement to acquire Venafi,…

byPallavi Madhiraju

May 21, 2024

web analytics